Pre-admission atrial fibrillation in COVID-19 patients: Prevalence and clinical impact
- PMID: 33810938
- PMCID: PMC7972716
- DOI: 10.1016/j.ejim.2021.03.017
Pre-admission atrial fibrillation in COVID-19 patients: Prevalence and clinical impact
Conflict of interest statement
No conflict of interest or any financial support to declare
Figures

References
-
- Russo V., Rago A., Carbone A., Bottino R., Ammendola E., Della Cioppa N., Galante D., Golino P., Nigro G. Atrial Fibrillation in COVID-19: from epidemiological association to pharmacological implications. J Cardiovasc Pharmacol. 2020;76(2):138–145. doi: 10.1097/FJC.0000000000000854. PMID: 32453074. - DOI - PubMed
-
- Ranieri V.M., Rubenfeld G.D., Thompson B.T., et al. ARDS definition task force. acute respiratory distress syndrome: the Berlin Definition. JAMA. 2012;307(23):2526–2533. - PubMed
-
- Silverio A., Di Maio M., Citro R., Esposito L., Iuliano G., Bellino M., et al. Cardiovascular risk factors and mortality in hospitalized patients with COVID-19: systematic review and meta-analysis of 45 studies and 18,300 patients. BMC Cardiovasc Disord. 2021 Jan 7;21(1):23. doi: 10.1186/s12872-020-01816-3. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical